Highlights
Positioning Equipment Improves Ergonomics for Medical Device Assembler
nl Ergonomic upgrades are becoming a vital part of many workplaces, and assembly workstations can be especially
3rd Annual Artificial Intelligence in Drug Development Congress
We will welcome over 450 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies,
Redbox Digital delivers scalable, robust omnichannel capability for Saudi's largest ph
- Nahdi sees a boost in traffic and conversions following launch -Jeddah – 10th April 2019. Redbox Digital has del
Pediatric Allergy and Asthma Meeting (PAAM 2019), Florence
This year EAACI will celebrate the 10th anniversary of its Pediatric Allergy and Asthma Meeting (PAAM 2019), taking plac
Cyber Security and Data Protection in Pharma and Healthcare Congress
We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and inter
Aging Conferences 2019
Geriatric Conferences 2019, Geriatrics Conferences, Palliative Care Conferences, Elderly Conference, Ageing Conferences
FDA Approves Evenity (romosozumab-aqqg) for the Treatment of Osteoporosis in Postmenopausa
April 9, 2019 -- The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis i
SmartLabs & Laboratory Informatics Congress
We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and inter
Medical Device Cybersecurity Conference to Address Vulnerabilities Facing Manufacturers an
The vulnerability of legacy devices and systems can threaten patient safety and data privacy. Learn how to face these
LSX World Congress USA
The LSX World Congress USA is a gathering of the industries foremost life science executive leaders.nlNow in itâ€
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patie
OLDWICK, N.J., April 9, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical com
Cosmo Pharmaceuticals Announces Submission of Remimazolam NDA to FDA
Dublin – April 9, 2019 – Cosmo Pharmaceuticals NV (SIX: COPN) today informed that the Remimazolam NDA has be